Literature DB >> 27840984

Long non‑coding RNA AK055347 is upregulated in patients with atrial fibrillation and regulates mitochondrial energy production in myocardiocytes.

Guiying Chen1, Hong Guo1, Ying Song1, Huiying Chang1, Shaojun Wang1, Miaomiao Zhang1, Chang Liu1.   

Abstract

The role of long non-coding RNAs (lncRNAs) in atrial fibrillation remains to be fully elucidated. The current study performed microarray analysis to investigate differential lncRNA expression profiling in atrial samples from the pulmonary vein and the surrounding left atrial area (LA‑PV) and from the left atrial appendage (LAA) in 16 patients with atrial fibrillation (AF). Microarray analysis identified 94 lncRNAs that were differentially expressed between the LA‑PV and LAA in patients with AF. AK055347 was one of lncRNAs with the most significant alterations observed. Knockdown of AK055347 inhibited cell viability of H9C2 cardiomyocytes, accompanied by downregulation of Cyp450 and ATP synthases. In addition, microarray analysis identified that MSS51 was a target of AK055347. Knockdown of AK055347 inhibited the expression of MSS51 in H9C2 cells. The observations of the current study suggest that lncRNAs are differentially expressed in the LA‑PV and LAA in patients with AF. AK055347 may contribute to the pathogenesis of AF by dysregulating mitochondrial energy production via regulation of Cyp450, ATP synthase and MSS51.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27840984     DOI: 10.3892/mmr.2016.5893

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  16 in total

Review 1.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

2.  Integrative analysis reveals essential mRNA, long non-coding RNA (lncRNA), and circular RNA (circRNA) in paroxysmal and persistent atrial fibrillation patients.

Authors:  Haoliang Sun; Junjie Zhang; Yongfeng Shao
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

3.  Manipulation of the miR-378a/mt-ATP6 regulatory axis rescues ATP synthase in the diabetic heart and offers a novel role for lncRNA Kcnq1ot1.

Authors:  Andrya J Durr; Quincy A Hathaway; Amina Kunovac; Andrew D Taylor; Mark V Pinti; Saira Rizwan; Danielle L Shepherd; Chris C Cook; Garrett K Fink; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-02       Impact factor: 4.249

Review 4.  Research Progress of LncRNAs in Atrial Fibrillation.

Authors:  Wenhui Wang; Bei Tian; Zhongping Ning; Xinming Li
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.695

Review 5.  Long noncoding RNAs coordinate functions between mitochondria and the nucleus.

Authors:  Yaru Dong; Takeshi Yoshitomi; Ji-Fan Hu; Jizhe Cui
Journal:  Epigenetics Chromatin       Date:  2017-08-23       Impact factor: 4.954

Review 6.  Mitoepigenetics and Its Emerging Roles in Cancer.

Authors:  Zhen Dong; Longjun Pu; Hongjuan Cui
Journal:  Front Cell Dev Biol       Date:  2020-01-23

7.  Long Noncoding RNA HOTAIR Functions as a Competitive Endogenous RNA to Regulate Connexin43 Remodeling in Atrial Fibrillation by Sponging MicroRNA-613.

Authors:  Weiran Dai; Xiaoying Chao; Shanshan Li; Shuang Zhou; Guoqiang Zhong; Zhiyuan Jiang
Journal:  Cardiovasc Ther       Date:  2020-11-17       Impact factor: 3.023

Review 8.  The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases.

Authors:  Ying Huang
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

Review 9.  Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System.

Authors:  Emre Bektik; Douglas B Cowan; Da-Zhi Wang
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

Review 10.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.